HomeIndustriesHealthcareMRNA, VRTX, REGN: The State Of The Biotech Market

MRNA, VRTX, REGN: The State Of The Biotech Market

Moderna’s (MRNA) forward visibility is starting to firm up and its Covid-19 revenue projections disappoint, but realistic in our view, notes Hartaj Singh. He discusses the state of the biotech market as MRNA shares hit a 3-year low last week. He talks about how MRNA’s spending, and margin pressure are still and issue. He also goes over Vertex Pharmaceuticals (VRTX) which is at a new 52-week high. He then looks at Regeneron (REGN) whose shares are up 15% year-to-date. Tune in to find out more about the stock market today.

Market On Close

06 Nov 2023

SHARE

ON AIR
3:00 am
Fast Market
replay
12:00 am
Market Overtime
REPLAY
12:30 am
Market On Close
REPLAY
education
2:00 am
Your First Trade
REPLAY
education
2:30 am
Your First Trade
REPLAY
ON AIR
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
5:00 am
Market Overtime
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Morning Movers
8:00 am
Opening Bell With Nicole Petallides
9:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Fast Market
REPLAY
5:00 pm
Next Gen Investing
REPLAY
6:00 pm
The Wrap
REPLAY
education
7:30 pm
Liz Ann Live
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market On Close
REPLAY
education
10:00 pm
Liz Ann Live
REPLAY
10:30 pm
The Wrap
REPLAY

Schwab Network's Newsletters

Daily insights for every investor